<code id='981B0C462B'></code><style id='981B0C462B'></style>
    • <acronym id='981B0C462B'></acronym>
      <center id='981B0C462B'><center id='981B0C462B'><tfoot id='981B0C462B'></tfoot></center><abbr id='981B0C462B'><dir id='981B0C462B'><tfoot id='981B0C462B'></tfoot><noframes id='981B0C462B'>

    • <optgroup id='981B0C462B'><strike id='981B0C462B'><sup id='981B0C462B'></sup></strike><code id='981B0C462B'></code></optgroup>
        1. <b id='981B0C462B'><label id='981B0C462B'><select id='981B0C462B'><dt id='981B0C462B'><span id='981B0C462B'></span></dt></select></label></b><u id='981B0C462B'></u>
          <i id='981B0C462B'><strike id='981B0C462B'><tt id='981B0C462B'><pre id='981B0C462B'></pre></tt></strike></i>

          Home / hotspot / hotspot

          hotspot


          hotspot

          author:entertainment    Page View:66726
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In